Literature DB >> 27595902

Ultrastructural investigation of the time-dependent relationship between breast cancer cells and thrombosis induction.

Wendy J van der Spuy1, Tanya N Augustine2.   

Abstract

Thromboembolic complications are a common cause of death in breast cancer patients. The in vivo relationship between coagulation factors and circulating tumours is a multifaceted one, with tumour cells implicated in thrombocytosis and platelets associated with coagulation-mediated metastasis. Platelets and fibrin networks are known to be morphologically altered in patients with cancer, and their relationship with breast cancer cells themselves may increase thrombosis susceptibility. This was investigated in vitro, assessing such morphological alterations through the establishment of a MCF-7 breast cancer cell co-culture system with blood plasma. Co-culture duration ranged from zero to thirty minutes, with five-minute intervals, in order to assess the time-dependent ultrastructural conformations of platelet and fibrin networks, using scanning electron microscopy. It was found that enhanced coagulability was related to co-culture duration. Changes in platelet and fibrin network morphology from normal were visible as early as five minutes in co-culture with MCF-7 cells. With longer co-culture duration thrombosis-linked variation in structural configuration was intensified, including advanced platelet aggregation and adherence characteristics, compression of fibrin networks into plaques of increased density, and upsurge of microparticulate extrusion implicated in amplifying procoagulant events during the metastatic process. These results confirm that cancer cells are stimulators of coagulation even in an in vitro system and breast cancer patients may become increasingly susceptible to thrombotic-related consequences with increased exposure to tumour cells, especially during metastasis.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fibrin network; Microparticle; Platelet; SEM; Ultrastructure

Mesh:

Substances:

Year:  2016        PMID: 27595902     DOI: 10.1016/j.micron.2016.08.006

Source DB:  PubMed          Journal:  Micron        ISSN: 0968-4328            Impact factor:   2.251


  5 in total

1.  Design and synthesis of nanoscaled IQCA-TAVV as a delivery system capable of antiplatelet activation, targeting arterial thrombus and releasing IQCA.

Authors:  Jianhui Wu; Haimei Zhu; Guodong Yang; Jianhong He; Yuji Wang; Shurui Zhao; Xiaoyi Zhang; Lin Gui; Ming Zhao; Shiqi Peng
Journal:  Int J Nanomedicine       Date:  2018-02-26

2.  Modifying ICCA with Trp-Phe-Phe to Enhance in vivo Activity and Form Nano-Medicine.

Authors:  Xiaoyi Zhang; Yixin Zhang; Yaonan Wang; Jianhui Wu; Haiyan Chen; Ming Zhao; Shiqi Peng
Journal:  Int J Nanomedicine       Date:  2020-01-21

3.  A Hypercoagulable Hematological Metastasis Breast Cancer Model.

Authors:  Wen-Jing Yang; Gan-Lin Zhang; Ke-Xin Cao; Guo-Wang Yang
Journal:  Biomed Res Int       Date:  2021-08-26       Impact factor: 3.411

4.  Incidence and Risk Factors for Venous Thromboembolism in Female Patients Undergoing Breast Surgery.

Authors:  Ambrogio P Londero; Serena Bertozzi; Carla Cedolini; Silvia Neri; Michela Bulfoni; Maria Orsaria; Laura Mariuzzi; Alessandro Uzzau; Andrea Risaliti; Giovanni Barillari
Journal:  Cancers (Basel)       Date:  2022-02-16       Impact factor: 6.639

5.  Design and development of ICCA as a dual inhibitor of GPIIb/IIIa and P-selectin receptors.

Authors:  Haiyan Chen; An Lu; Xiaoyi Zhang; Lin Gui; Yaonan Wang; Jianhui Wu; Hua Feng; Shiqi Peng; Ming Zhao
Journal:  Drug Des Devel Ther       Date:  2018-07-09       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.